The
Global Biopsy
Forceps Market is subject to witness a substantial growth due to
the rising occurrence of cancer and increasing demand from both developed and
developing economies across the globe. Increasing healthcare expenditure and
recent improvements in the healthcare infrastructure, particularly in the Asia
Pacific region are expected to fuel market demand for biopsy forceps in the
upcoming years. Globally, the biopsy forceps market is predicted to grow at
CAGR of 6.5% in the forecast period, providing numerous opportunities for
market players to invest in research and development of the biopsy forceps
devices.
Soaring
demand for advanced analytical techniques for treatment of cancer is predicted
to favor market growth in the upcoming years. In addition, surging need for
fewer intrusive surgeries and disposable biopsy instruments is projected to
foster the growth of market over the forecast period. The recent technological
advancement coupled with development of the novel products & techniques
such as advanced biopsy guidance systems and vacuum assisted guns are expected
to provide platform for the sustained growth of biopsy forceps market in
upcoming years.
Growing
popularity of the biopsy forceps devices in patients and healthcare
professionals offer lucrative growth opportunities for industry players in the
forecast period. Growing geriatric population and emergence of cost effective
solution are propelling the market growth in recent years. As per recent
reports published by WHO (World Health Organization), cancer is considered to
be one of the major causes of death across the globe.
Growing
prevalence of cancer and cancer related diseases drives the market demand for
biopsy forceps devices in the upcoming years. Changing lifestyle patterns,
increasing smoking population across the globe and varying food habits are
considered as major causes of cancer. Rising incidences of fatal cancer among
patients such as colorectal cancer, breast cancer, lung cancer, liver cancer,
and stomach cancer are projected to boost market growth. Almost 23.6 million
people around the globe are expected to display cancer symptoms by next decade.
Demand for highly effective, safer, and enhanced biopsy procedures is one the
rise. Additionally, development of minimally invasive medical procedures that
offers numerous advantages over traditional procedures are boosting market
value of biopsy forceps devices, in the last few years. Minimally invasive
medical procedures offer faster recovery of patients and are less traumatic.
The
market is broadly categorized into four major types based on product type such
as needle-based biopsy guns, biopsy guidance systems, biopsy needles, and
biopsy forceps. The needle-based biopsy guns is considered as one of the
fastest growing segment in the biopsy forceps market with substantial revenue
generation in the last couple of years. Growing popularity of the needle-based
biopsy guns segment is attributed to growing requirements of these devices to
carry out diagnosis of soft tissues of internal organs such as breasts,
kidneys, and lungs. Factors responsible for sustained growth of the
needle-based biopsy guns segment include development of aspiration biopsy
syringe guns to perform complex diagnosis procedures.
The
market is divided by region as North America, Europe, Asia-Pacific, Latin
America and Africa. North America has shown major growth in recent years owing
to the rise in the implementation of latest technologies in pharmaceuticals
& medicine sector, higher penetration rates of advanced devices like vacuum
assisted biopsy systems, increase in demand for disposable devices from
healthcare professionals, and existence of well-established healthcare
infrastructure in the region. Asia-Pacific region is predicted to hold major
market share in the biopsy forceps market with massive growth in forecast
period. Countries such as India, China and South Korea are leading the
Asia-Pacific market with increasing healthcare expenditure, growing prevalence
of cancer related diseases, presence of high-unmet patient needs, and
significant investment by leading industry players considering potential growth
opportunities in the region.
The
key players in the biopsy forceps market are Inard Inc., Carefusion Co.,
Devicor Medical Products, Inc., DTR Medical, Ltd., Hologic Inc., C.R. Bard
Inc., Biopsy Sciences LLC, and Cardinal Health Inc.
Market Segment:
Key Regions
•
North America
•
Europe
•
Asia Pacific
•
Middle East and Africa
•
South America
Key Vendors
•
Argon Medical
•
Boston Scientific
•
Changzhou Jiuhong
•
Conmed
•
Cook Medical
•
FUJIFILM Corporation
•
Halyard Health
Comments
Post a Comment